Envoy Medical (COCH) Stock Price, News & Analysis

Company Overview

Envoy Medical is a medical technology company focused on developing fully implanted hearing devices for people with sensorineural hearing loss. Unlike conventional hearing aids and many cochlear implants, its technology is designed to be placed beneath the skin, with no external wearable sound processor.

The company’s lead product is the Acclaim Cochlear Implant, a fully implanted cochlear implant intended to address moderate-to-profound sensorineural hearing loss in adults. The system is designed to use the body’s natural anatomy to capture sound and convert it into electrical signals that stimulate the auditory nerve. Envoy Medical has also developed the Esteem Fully Implanted Active Middle Ear Implant, an earlier device based on similar fully implanted hearing technology.

Envoy Medical is headquartered in White Bear Lake, Minnesota, and has focused primarily on the U.S. hearing-loss treatment market. The company was founded in 1995 and became publicly traded in 2023. Brent Lucas serves as chief executive officer. Its Acclaim system has been evaluated through clinical development and regulatory processes as the company works toward broader commercialization.

Key Stats

• Today's Range: $6.80 to $6.92
• 50-Day Range: $5.96 to $7.43
• 52-Week Range: $3.63 to $9.54
• Volume: 12,917 shs
• Average Volume: 39,270 shs
• Market Capitalization: $52.57 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $21.00
• Consensus Rating: Hold

Envoy Medical Stock Analysis - MarketRank™

Envoy Medical scored higher than 66% of companies evaluated by MarketBeat, and ranked 273rd out of 892 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.7 / 5
• Analyst Rating: Hold

Consensus Rating

Envoy Medical has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on no strong buy ratings, 2 buy ratings, 1 hold rating, and 1 sell rating.

Upside Potential

Envoy Medical has a consensus price target of $21.00, representing about 208.4% upside from its current price of $6.81.

Amount of Analyst Coverage

Envoy Medical has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Envoy Medical are expected to grow in the coming year, from ($2.61) to ($2.25) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Envoy Medical is -1.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Envoy Medical is -1.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.26% of the float of Envoy Medical has been sold short.

Short Interest Ratio / Days to Cover

Envoy Medical has a short interest ratio ("days to cover") of 2.67, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Envoy Medical has recently decreased by 84.42%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Envoy Medical does not currently pay a dividend.

Dividend Growth

Envoy Medical does not have a long track record of dividend growth.

News and Social Media

• Score: 2.6 / 5
• News Sentiment: 0.13

News Sentiment

Envoy Medical has a news sentiment score of 0.13. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.58 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 13 news articles for Envoy Medical this week, compared to 2 articles on an average week.

MarketBeat Follows

2 people have added Envoy Medical to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.4 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Envoy Medical insiders have not sold or bought any company stock.

Percentage Held by Insiders

7.20% of the stock of Envoy Medical is held by insiders.

Percentage Held by Institutions

8.59% of the stock of Envoy Medical is held by institutions.

Company Calendar

• Last Earnings: 11/05/2026
• Today: 11/12/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NASDAQ:COCH
• CIK: 1840877
• Web: www.envoymedical.com
• Phone: (651) 361-8000
• Fax: N/A
• Employees: 47
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Envoy Medical: $21.00
• High Price Target: $25.00
• Low Price Target: $18.00
• Potential Upside/Downside: +208.4%
• Consensus Rating: Hold
• Rating Score (0-4): 2.25
• Research Coverage: 4 Analysts

Profitability

• EPS (Trailing Twelve Months): ($4.60)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$23.76 million
• Net Margins: -9,026.41%
• Pretax Margin: -9,026.41%
• Return on Equity: -5,250.23%
• Return on Assets: -112.19%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.21
• Quick Ratio: 1.61

Sales & Book Value

• Annual Sales: $240 thousand
• Price / Sales: 219.06
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.20) per share
• Price / Book: -34.05

Miscellaneous

• Outstanding Shares: 7,720,000
• Free Float: 7,164,000
• Market Cap: $52.57 million
• Optionable: Not Optionable
• Beta: 2.03